Novogene: As of now, the company has not collaborated with Huawei, Tencent, and others in the field of large models

Novogene announced that it is currently not collaborating with companies such as Huawei and Tencent in the field of large models. The company is actively exploring the application of AI technology, and the developed AI bioinformatics expert "Novi" has been provided to customers for free, but it has not yet generated revenue and does not involve diagnostic and testing services, reminding investors to be aware of investment risks

According to the Zhitong Finance APP, Novogene (688315.SH) announced a stock price fluctuation, stating that AI technology is developing rapidly, and the company is actively exploring the application of AI technology in its business. Currently, the AI bioinformatics intelligent expert "Novi" developed by the company is provided to customers for free, and it has not yet generated revenue, nor does it involve diagnostic and testing services. Investors are advised to pay attention to investment risks. As of now, the company has not collaborated with Huawei, Tencent, and others in the field of large models